Cargando…

Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer

BACKGROUND: Platinum based agents—cisplatin and carboplatin in combination with taxanes are used for the treatment of ovarian cancer (OC) patients. However, the majority of OC patients develop recurrent, platinum resistant disease that is uniformly fatal. Platinum treatment enriches for chemoresista...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sriramkumar, Shruthi, Sood, Riddhi, Huntington, Thomas D., Ghobashi, Ahmed H., Vuong, Truc T., Metcalfe, Tara X., Wang, Weini, Nephew, Kenneth P., O’Hagan, Heather M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153190/ https://www.ncbi.nlm.nih.gov/pubmed/35641987 http://dx.doi.org/10.1186/s12967-022-03447-y

Ejemplares similares

A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer
por: Muralikrishnan, Vaishnavi, et al.
Publicado: (2022)

Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment
por: Sriramkumar, Shruthi, et al.
Publicado: (2022)

The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
por: Savant, Sudha S., et al.
Publicado: (2018)

Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer
por: Ghobashi, Ahmed H., et al.
Publicado: (2023)

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells
por: Pulliam, Nicholas, et al.
Publicado: (2019)

Impaired OXPHOS Complex III in Breast Cancer
por: Owens, Kjerstin M., et al.
Publicado: (2011)

Decitabine reactivated pathways in platinum resistant ovarian cancer
por: Fang, Fang, et al.
Publicado: (2014)

Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
por: Chen, Chia-Lin, et al.
Publicado: (2021)

DVL regulation of tissue-specific aromatase transcripts in breast cancer
por: O’Hagan, Heather M.
Publicado: (2018)

Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
por: Bulle, Ashenafi, et al.
Publicado: (2020)

Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS
por: Chen, Vivian, et al.
Publicado: (2012)

Mitoribosomal regulation of OXPHOS biogenesis in plants
por: Janska, Hanna, et al.
Publicado: (2014)

Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
por: Kawamata, Hibiki, et al.
Publicado: (2017)

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer
por: Patel, Monal, et al.
Publicado: (2021)

Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
por: Masoud, Rawand, et al.
Publicado: (2020)

Correction: Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
por: Kawamata, Hibiki, et al.
Publicado: (2018)

Infrequent Offenders: Neuroendocrine Tumors and Cancers of the Appendix, Gallbladder, and Bile Duct
por: O’Hagan, Kristen
Publicado: (2021)

EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
por: Chebouti, Issam, et al.
Publicado: (2017)

Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study
por: Benson, Eric A., et al.
Publicado: (2015)

Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
por: Fiorillo, Marco, et al.
Publicado: (2016)

Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
por: Hirpara, Jayshree, et al.
Publicado: (2018)

Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
por: Chen, Chia-Lin, et al.
Publicado: (2021)

A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC–OXPHOS axis
por: Jiang, Ruibin, et al.
Publicado: (2023)

Parallel Structural Evolution of Mitochondrial Ribosomes and OXPHOS Complexes
por: van der Sluis, Eli O., et al.
Publicado: (2015)

Human diseases associated with defects in assembly of OXPHOS complexes
por: Ghezzi, Daniele, et al.
Publicado: (2018)

Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia
por: Nelson, Margaret AM, et al.
Publicado: (2021)

Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
por: Adant, Isabelle, et al.
Publicado: (2022)

Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types
por: Boykov, Ilya N., et al.
Publicado: (2023)

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
por: Li, Meng, et al.
Publicado: (2009)

Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells
por: Invernizzi, F., et al.
Publicado: (2012)

The molecular evolutionary dynamics of oxidative phosphorylation (OXPHOS) genes in Hymenoptera
por: Li, Yiyuan, et al.
Publicado: (2017)

Zelkovamycin is an OXPHOS Inhibitory Member of the Argyrin Natural Product Family
por: Krahn, Daniel, et al.
Publicado: (2020)

OXPHOS Organization and Activity in Mitochondria of Plants with Different Life Strategies
por: Ukolova, Irina V., et al.
Publicado: (2023)

Two-compartment tumor metabolism: Autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells
por: Salem, Ahmed F., et al.
Publicado: (2012)

5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
por: Denise, Corti, et al.
Publicado: (2015)

OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
por: Schöpf, Bernd, et al.
Publicado: (2020)

OXPHOS-dependent metabolic reprogramming prompts metastatic potential of breast cancer cells under osteogenic differentiation
por: Hu, Yangling, et al.
Publicado: (2020)

ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy
por: Yasukawa, Maya, et al.
Publicado: (2016)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity
por: Yeo, Janet H. C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s0p2kap3nrogoq80as3pp3ngm6